PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists stack up new genes for height

Competitors become collaborators to achieve a common goal: The discovery of genes that influence height

2010-09-30
(Press-News.org) CHAPEL HILL – An international team of researchers, including a number from the University of North Carolina at Chapel Hill schools of medicine and public health, have discovered hundreds of genes that influence human height.

Their findings confirm that the combination of a large number of genes in any given individual, rather than a simple "tall" gene or "short" gene, helps to determine a person's stature. It also points the way to future studies exploring how these genes combine into biological pathways to impact human growth.

"While we haven't explained all of the heritability of height with this study, we have confidence that these genes play a role in height and now can begin to learn about the pathways in which these genes play a role," said study coauthor Karen L. Mohlke, PhD, associate professor of genetics in the UNC School of Medicine.

The study, which appears online Sept. 29, 2010, in the journal Nature, is the result of the largest consortium of researchers to ever study the trait. The consortium, aptly named GIANT for Genetic Investigation of ANthropometric Traits.

Traits, brought together hundreds of investigators from dozens of countries, to identify which genes affect height in almost two hundred thousand different individuals.

"These investigators had once been competing with each other to find height genes, but then realized that the next step was to combine their samples and see what else could be found," said Mohlke. "The competitors became collaborators to achieve a common scientific goal."

That pooling of resources was necessary because the scientists knew that height was a complex genetic trait, with possibly a number of genes of small effect each adding up to influence whether a person would be taller or shorter. In this large study, forty-six smaller genome-wide association studies of height were combined and then analyzed statistically, yielding 180 different regions or genetic loci that influence the trait. "These common gene variants could explain as much as sixteen percent of the variation in height," said study co-author Kari North, PhD, associate professor of epidemiology in the UNC Gillings School of Global Public Health.

The researchers looked to see whether the 180 regions contained more genes that underlie skeletal growth defects than would be expected if those regions were just chosen randomly across the genome. They found that the genes were not random and could in fact point to functional pathways important in influencing height.

Members of the consortium are working to uncover the "missing heritability" – the proportion of inherited variation in height that is still unexplained. Because this study looked for common genetic variants, the researchers are now going after rare genetic variants that may also play a role.

"This work is giving the field important insights into skeletal growth, height and growth defects," said Mohlke. "And it is also showing us how similar approaches can be taken to look for genes underlying other common traits and diseases relevant to body size, like type 2 diabetes."

INFORMATION:

Also from UNC is co-author Keri L. Monda, PhD, research assistant professor in epidemiology in the Gillings School of Global Public Health. The research was funded by the National Institutes of Health.

END



ELSE PRESS RELEASES FROM THIS DATE:

For the first time, monkeys recognize themselves in the mirror, indicating self-awareness

2010-09-30
EDITOR'S NOTE: An image and video are available at http://www.news.wisc.edu/newsphotos/macaque-mirror.html The study, with several videos of the monkeys, appears in today's PLoS One, at http://dx.plos.org/10.1371/journal.pone.0012865 END ...

Research on killer HIV antibodies provides promising new ideas for vaccine design

2010-09-30
New discoveries about the immune defenses of rare HIV patients who produce antibodies that prevent infection suggest a novel direction for designing new vaccines. Researchers at Rockefeller University and colleagues have now made two fundamental discoveries about the so called broadly neutralizing anti-HIV antibodies, which effectively keep the virus at bay. By detailing the molecular workings of a proven immune response, the researchers hope their work will ultimately enable them to similarly arm those who are not equipped with this exceptional immunological firepower. ...

Increased risk of other cancers for relatives of women with early onset breast cancer

2010-09-30
Close relatives of women diagnosed with breast cancer before the age of 35 years are at an increased risk of developing other cancers, according to a University of Melbourne study, published in the British Journal of Cancer today. Professor John Hopper, Director of Research from the Centre for Molecular, Environmental, Genetic and Analytic Epidemiology at the University of Melbourne, Australia, a lead investigator in the study, said these are surprising and novel findings which could be pointing to the existence of a new cancer genetic syndrome. "The results suggest ...

Diet when young affects future food responses

2010-09-30
A high protein diet during development primes the body to react unhealthily to future food binges. A study on juvenile rats, published in BioMed Central's open access journal Nutrition and Metabolism, suggests that lasting changes result from altering the composition of the first solid food that is consumed throughout growth into early adulthood. Raylene Reimer worked with a team of researchers from the University of Calgary, Canada, to carry out the weaning experiments in 18 litters of rats. Six litters were placed on each of three diets: high prebiotic fiber, high ...

Newly discovered planet may be first truly habitable exoplanet

2010-09-30
SANTA CRUZ, CA--A team of planet hunters led by astronomers at the University of California, Santa Cruz, and the Carnegie Institution of Washington has announced the discovery of an Earth-sized planet (three times the mass of Earth) orbiting a nearby star at a distance that places it squarely in the middle of the star's "habitable zone," where liquid water could exist on the planet's surface. If confirmed, this would be the most Earth-like exoplanet yet discovered and the first strong case for a potentially habitable one. To astronomers, a "potentially habitable" planet ...

A 'giant' step toward explaining differences in height

2010-09-30
Boston, Mass. -- An international collaboration of more than 200 institutions, led by researchers at Children's Hospital Boston, the Broad Institute, and a half-dozen other institutions in Europe and North America, has identified hundreds of genetic variants that together account for about 10 percent of the inherited variation of height among people. Known as the GIANT (Genetic Investigation of ANthropometric Traits) Consortium, the collaboration pooled data from more than 180,000 individuals, including millions of genetic results from each of 46 separate studies in the ...

Potentially habitable planet discovered

2010-09-30
Washington, D.C. Astronomers have found a new, potentially habitable Earth-sized planet. It is one of two new planets discovered around the star Gliese 581, some 20 light years away. The planet, Gliese 581g, is located in a "habitable zone"—a distance from the star where the planet receives just the right amount of stellar energy to maintain liquid water at or near the planet's surface. The 11- year study, published in the Astrophysical Journal and posted online at arXiv.org, suggests that the fraction of stars in the Milky Way harboring potentially habitable planets could ...

New drug offers big relief for osteoarthritis pain

2010-09-30
CHICAGO --- A phase II clinical trial of the first new type of drug for musculoskeletal pain since aspirin shows that it significantly reduces knee pain in osteoarthritis, the most common osteoarthritis pain, according to new research from Northwestern Medicine. However, phase III trials of that drug, tanezumab, have been placed on clinical hold after 16 out of several thousand participants in the new trial developed progressively worsening arthritis and bone changes that required total joint replacements. "The bottom line is this is a very effective drug for relieving ...

Albert Einstein College of Medicine researcher among global team investigating genetics of height

2010-09-30
September 29, 2010 ─ (BRONX, NY) ─ A seemingly simple inherited trait – height – springs from hundreds of genetic causes, according to an international team of scientists. Robert Kaplan, Ph.D., professor of epidemiology & population health at Albert Einstein College of Medicine of Yeshiva University, is co-author of a paper on the group's findings published in the September 29 online edition of Nature. The study identified hundreds of gene variants in at least 180 locations that influence adult height. These results prove that with internet technology it ...

3 tiny qubits, another big step toward quantum computing

2010-09-30
New Haven, Conn.—The rules that govern the world of the very small, quantum mechanics, are known for being bizarre. One of the strangest tenets is something called quantum entanglement, in which two or more objects (such as particles of light, called photons) become inextricably linked, so that measuring certain properties of one object reveals information about the other(s), even if they are separated by thousands of miles. Einstein found the consequences of entanglement so unpalatable he famously dubbed it "spooky action at a distance." Now a team led by Yale researchers ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Scientists stack up new genes for height
Competitors become collaborators to achieve a common goal: The discovery of genes that influence height